ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
Younger age doubles medium-term revision risk after total knee arthroplasty: A nationwide multicenter cohort of 5980 knees from the French SCORE I registry.
Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAlthough age is a known predictor of outcomes following total knee arthroplasty (TKA), most large-scale studies rely on registry data that lack clinical detail and combines multiple implant designs. This study aimed to determine whether age has an independent effect on implant survivorship and clinical outcomes when a single TKA design is used in a national cohort.
methodsA multicenter retrospective cohort analysis was performed using the Amplitude® registry, which prospectively recorded every primary TKA done with the same implant across 15 healthcare facilities between 2002 and 2022. Patients were grouped a priori into three age brackets: <65 years, 65-79 years and >79 years. The primary endpoint was revision-free survival; the secondary endpoints were surgery-free survival, the International Knee Society Score score and knee flexion at one and five years postoperative. Survival analyses were adjusted for sex, body mass index (BMI), American Society of Anesthesiologists (ASA) grade, fixation type and navigation use.
resultsOf the 5980 TKAs included, 1276 were in patients <65 years, 3589 in those 65-79 and 1115 in patients >79. The 5-year revision-free survival was 97.5% (<65 years), 98.9% (65-79 years) and 98.7% (>79 years). Compared to the 65-79 year-old group, patients <65 had twice the risk of revision (adjusted hazard ratio [HR] 2.03; 95% confidence interval [CI] 1.20-3.43; p = 0.008), while no difference was found for those >79 (HR 1.14; p = 0.728). Surgery-free survival and complications followed similar trends. No interaction between age and sex, BMI, ASA, fixation or navigation was observed. Functional outcomes improved across all ages; younger patients had higher KSS, but age had no effect on postoperative flexion.
conclusionsAge is an independent predictor of implant survivorship following TKA. While younger patients have good functional outcomes, they remain the Achilles heel of TKA due to their higher risk of revision, whereas patients >79 years of age have comparable implant longevity to 65-79-year-old patients. LEVEL OF EVIDENCE: Level III retrospective comparative study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.